Table 2.
Laboratory examination data of Group A and Group B.
| Reference range | Total average (n = 182) | Group A (n = 149) | Group B (n = 33) | P value | |
|---|---|---|---|---|---|
| WBC (/µL) | 2700–8800 | 7819.3 ± 4816.8 | 6238.6 ± 2213.6 | 15353.3 ± 6734.2 | <0.001 |
| Platelet (/µL) | 14–34 | 21.4 ± 8.9 | 22.1 ± 8.5 | 18.6 ± 10.7 | 0.1009 |
| AST (U/L) | 8–38 | 136.0 ± 171.3 | 124.4 ± 164.3 | 197.4 ± 198.7 | 0.0884 |
| ALT (U/L) | 4–44 | 146.9 ± 184.9 | 146.9 ± 182.0 | 150.7 ± 206.2 | 0.9490 |
| γ-GTP (U/L) | 16–73 | 480.0 ± 609.6 | 484.6 ± 634.6 | 462.0 ± 487.9 | 0.7724 |
| T-Bil (mg/dL) | 0.2–1.2 | 4.0 ± 5.7 | 3.8 ± 5.9 | 4.6 ± 5.1 | 0.4991 |
| ALB (g/dL) | 3.9–5.3 | 3.1 ± 0.7 | 3.2 ± 0.7 | 2.7 ± 0.8 | 0.0006 |
| CRP (mg/dL) | <0.3 | 11.2 ± 73.8 | 10.6 ± 81.0 | 15.1 ± 7.1 | 0.6181 |
Group A: control group consisting of patients with mild acute cholangitis or without acute cholangitis.
Group B: more severe general condition group consisting of patients with severe or moderate acute cholangitis.
WBC: white blood cells, AST: aspartate aminotransferase, ALT: alanine aminotransferase, γ-GTP: γ-glutamyl transpeptidase, T-Bil: total bilirubin, ALB: albumin, and CRP: C-reactive protein.